Taghipour-Zahir S

No ORCID on file · 1 paper in corpus · active 2020
2020
Can the prophylactic quadrivalent HPV vaccine be used as a therapeutic agent in women with CIN? A randomized trial.
BMC public health ·doi:10.1186/s12889-020-8371-z

BackgroundHuman papillomavirus (HPV) is one of the most significant risk factors for cervical cancer. The HPV vaccine has a very significant impact on the incidence of cervical cancer. The present study aimed to investigate the impact of pr…